Safety of TG100-115 for Heart Attack Treated With Angioplasty
Myocardial Infarction
About this trial
This is an interventional treatment trial for Myocardial Infarction focused on measuring myocardial infarction, infarct size, angioplasty, percutaneous coronary intervention, Acute Myocardial Infarction
Eligibility Criteria
Inclusion Criteria: Age 18-80 yrs ECG patterns consistent with an acute anterior myocardial infarction with ST segment elevation of 2mm in two contiguous ECG leads among leads V1-V4. Have prolonged, continuous (lasting at least 20 mins) signs and symptoms of myocardial ischemia not eliminated with nitrates. Intent to proceed to primary PCI within 6 hours of chest pain onset Sign an informed consent form and be willing to attend follow-up visits for safety and other study assessments. Exclusion Criteria: Female of childbearing potential. History of previous myocardial infarction. History of congestive heart failure. Requirement for a cardiac pacemaker or defibrillator. Cardiogenic shock. Patients previously treated with thrombolytic therapy. Myocardial ischemia precipitated by a condition other than atherosclerotic coronary artery disease.
Sites / Locations
- David Holmes, MD